Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
We initiate a study with research grant from department of health and Taoyuan mental hospital
and choose risperidone and olanzapine as study medications. We compare the effects of these 2
drugs in schizophrenic spectrum patients of Han ethnics with neuroleptic-induced tardive
dyskinesia to test the hypothesis that these two medications have different effects in
improving tardive dyskinesia.
Phase:
Phase 4
Details
Lead Sponsor:
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan